Assignee
AMGEN INC
US·1,642 granted patents·958 pending applications·35,470 citations·filing 1984–2025
Top patents by PatentIndex Score
2,600 records- 0199USD1001272SAutoinjector with removable capAMGEN INC·Filed 2021·Granted Oct 10, 2023·37 cites·1 claims
- 0299USD922567SAutoinjector with removable capAMGEN INC·Filed 2020·Granted Jun 15, 2021·43 cites·1 claims
- 0399USD898189SAutoinjector with removable capAMGEN INC·Filed 2020·Granted Oct 6, 2020·50 cites·1 claims
- 0499US8859741B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 14, 2014·51 cites·24 claims
- 0599US8829165B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2013·Granted Sep 9, 2014·76 cites·29 claims
- 0699US8030457B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2008·Granted Oct 4, 2011·175 cites·27 claims
- 0799US7915391B2Humanized c-Kit antibodyAMGEN INC·Filed 2007·Granted Mar 29, 2011·112 cites·10 claims
- 0898US11993597B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2022·Granted May 28, 2024·8 cites·50 claims
- 0998US11905281B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2020·Granted Feb 20, 2024·13 cites·16 claims
- 1098US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 1198US11306087B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2020·Granted Apr 19, 2022·16 cites·55 claims
- 1298US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 1398US10640504B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2018·Granted May 5, 2020·50 cites·71 claims
- 1498USD878560SAutoinjector with removable capAMGEN INC·Filed 2018·Granted Mar 17, 2020·59 cites·1 claims
- 1598US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 1698US10519146B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2018·Granted Dec 31, 2019·81 cites·33 claims
- 1798US10344016B2Bromotriazole intermediatesAMGEN INC·Filed 2018·Granted Jul 9, 2019·8 cites·5 claims
- 1898USD851754SAutoinjector with removable capAMGEN INC·Filed 2018·Granted Jun 18, 2019·69 cites·1 claims
- 1998USD819198SAutoinjector with removable capAMGEN INC·Filed 2016·Granted May 29, 2018·80 cites·1 claims
- 2098USD814022SAutoinjector with removable capAMGEN INC·Filed 2016·Granted Mar 27, 2018·83 cites·1 claims
- 2198US9842408B2Methods and apparati for nondestructive detection of undissolved particles in a fluidAMGEN INC·Filed 2016·Granted Dec 12, 2017·29 cites·12 claims
- 2298US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 2398US8999917B2Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2013·Granted Apr 7, 2015·48 cites·19 claims
- 2498US8883983B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 11, 2014·26 cites·30 claims
- 2598US8871914B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·25 claims
- 2698US8871913B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·29 claims
- 2798US8361963B2Uses of FGF21 polypeptides comprising two or more mutationsAMGEN INC·Filed 2011·Granted Jan 29, 2013·64 cites·4 claims
- 2898US8034770B2FGF21 polypeptides comprising two or more mutationsAMGEN INC·Filed 2009·Granted Oct 11, 2011·63 cites·15 claims
- 2998US7879323B2Antibodies to fibroblast growth factor-like polypeptidesAMGEN INC·Filed 2008·Granted Feb 1, 2011·45 cites·12 claims
- 3098US7767206B2Neutralizing determinants of IL-17 Receptor A and antibodies that bind theretoAMGEN INC·Filed 2007·Granted Aug 3, 2010·76 cites·8 claims
- 3198US7667008B2Fibroblast growth factor-like polypeptides and variants thereofAMGEN INC·Filed 2007·Granted Feb 23, 2010·65 cites·19 claims
- 3298US7442778B2Modified Fc moleculesAMGEN INC·Filed 2005·Granted Oct 28, 2008·140 cites·14 claims
- 3398US7364736B2Antibodies to OPGLAMGEN INC·Filed 2002·Granted Apr 29, 2008·97 cites·25 claims
- 3498US7282504B2Kinase inhibitorsAMGEN INC·Filed 2005·Granted Oct 16, 2007·90 cites·11 claims
- 3598US7138370B2Specific binding agents of human angiopoietin-2AMGEN INC·Filed 2002·Granted Nov 21, 2006·100 cites·25 claims
- 3698US6919426B2Peptides and related molecules that modulate nerve growth factor activityAMGEN INC·Filed 2003·Granted Jul 19, 2005·256 cites·3 claims
- 3798US6660843B1Modified peptides as therapeutic agentsAMGEN INC·Filed 1999·Granted Dec 9, 2003·631 cites·10 claims
- 3898US6096728AComposition and method for treating inflammatory diseasesAMGEN INC·Filed 1997·Granted Aug 1, 2000·322 cites·20 claims
- 3998US5824784AN-terminally chemically modified protein compositions and methodsAMGEN INC·Filed 1994·Granted Oct 20, 1998·779 cites·12 claims
- 4097US12102808B2Drug delivery deviceAMGEN INC·Filed 2020·Granted Oct 1, 2024·12 cites·17 claims
- 4197USD1023290SAutoinjector with removable capAMGEN INC·Filed 2023·Granted Apr 16, 2024·13 cites·1 claims
- 4297USD985119SHandheld drug delivery deviceAMGEN INC·Filed 2021·Granted May 2, 2023·47 cites·1 claims
- 4397USD974547SHandheld drug delivery deviceAMGEN INC·Filed 2020·Granted Jan 3, 2023·54 cites·1 claims
- 4497USD973866SHandheld drug delivery deviceAMGEN INC·Filed 2020·Granted Dec 27, 2022·48 cites·1 claims
- 4597USD958329SHandheld drug delivery deviceAMGEN INC·Filed 2020·Granted Jul 19, 2022·64 cites·1 claims
- 4697US11298463B2Method of assembling and filling a drug delivery deviceAMGEN INC·Filed 2020·Granted Apr 12, 2022·6 cites·25 claims
- 4797US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 4897US11096939B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 24, 2021·24 cites·30 claims
- 4997US11045484B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Jun 29, 2021·24 cites·34 claims
- 5097US10988485B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Apr 27, 2021·27 cites·51 claims
Showing the top 50 of 2,600 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AMGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →